WEBSITE BSE:543252 NSE : FAIRCHEMOR 10 May, 16:01
Market Cap ₹1812 Cr.
Stock P/E 44.6
P/B 6.5
Current Price ₹1391.4
Book Value ₹ 213.7
Face Value 10
52W High ₹1525.3
Dividend Yield 0.54%
52W Low ₹ 999
Fairchem Organics Ltd manufactures and sells speciality oleo chemicals and intermediate nutraceuticals in India. It also offers nutraceuticals comprising combined tocopherol and sterol concentrate; and oleo chemical compounds, which include dimer, linoleic, monomer, and distilled fatty acid products. The organization incorporated in 2019 and is primarily based in Ahmedabad, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 168 | 158 | 178 | 225 | 169 | 102 | 152 | 161 | 152 | 148 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 168 | 159 | 178 | 225 | 169 | 103 | 152 | 161 | 153 | 148 |
Total Expenditure | 136 | 137 | 159 | 185 | 159 | 99 | 133 | 149 | 135 | 128 |
Operating Profit | 32 | 21 | 19 | 40 | 9 | 4 | 19 | 12 | 17 | 20 |
Interest | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 28 | 18 | 15 | 36 | 6 | 1 | 16 | 8 | 14 | 17 |
Provision for Tax | 7 | 5 | 4 | 9 | 2 | 0 | 4 | 2 | 4 | 4 |
Profit After Tax | 21 | 13 | 11 | 27 | 4 | 1 | 12 | 6 | 10 | 12 |
Adjustments | -0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 21 | 13 | 11 | 27 | 4 | 1 | 12 | 6 | 10 | 12 |
Adjusted Earnings Per Share | 16 | 10.3 | 8.6 | 20.8 | 3.1 | 0.5 | 9.1 | 4.7 | 7.9 | 9.5 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 306 | 397 | 643 | 648 | 613 |
Other Income | 7 | 0 | 0 | 1 | 0 |
Total Income | 313 | 397 | 644 | 649 | 614 |
Total Expenditure | 258 | 328 | 538 | 576 | 545 |
Operating Profit | 55 | 69 | 105 | 73 | 68 |
Interest | 7 | 7 | 7 | 6 | 4 |
Depreciation | 6 | 7 | 7 | 8 | 8 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 42 | 56 | 91 | 59 | 55 |
Provision for Tax | 8 | 13 | 23 | 15 | 14 |
Profit After Tax | 35 | 42 | 68 | 44 | 40 |
Adjustments | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 35 | 42 | 68 | 44 | 40 |
Adjusted Earnings Per Share | 0 | 32.6 | 52.2 | 33.4 | 31.2 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 1% | 28% | 0% | 0% |
Operating Profit CAGR | -30% | 10% | 0% | 0% |
PAT CAGR | -35% | 8% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 15% | 17% | NA% | NA% |
ROE Average | 18% | 27% | 28% | 28% |
ROCE Average | 21% | 30% | 29% | 29% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 127 | 169 | 232 | 259 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 16 | 26 | 10 | 0 |
Other Non-Current Liabilities | 13 | 13 | 15 | 16 |
Total Current Liabilities | 63 | 51 | 67 | 67 |
Total Liabilities | 219 | 259 | 324 | 342 |
Fixed Assets | 126 | 126 | 141 | 156 |
Other Non-Current Assets | 18 | 34 | 46 | 38 |
Total Current Assets | 75 | 98 | 137 | 149 |
Total Assets | 219 | 259 | 324 | 342 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 31 | 40 | 40 | 50 |
Cash Flow from Investing Activities | -24 | -23 | -34 | -14 |
Cash Flow from Financing Activities | -7 | -17 | -6 | -35 |
Net Cash Inflow / Outflow | 0 | -0 | -0 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 32.63 | 52.15 | 33.41 |
CEPS(Rs) | 0 | 37.68 | 57.63 | 39.67 |
DPS(Rs) | 0 | 3.5 | 13 | 7.5 |
Book NAV/Share(Rs) | 0 | 129.59 | 178.29 | 199.11 |
Core EBITDA Margin(%) | 15.78 | 17.36 | 16.3 | 11.16 |
EBIT Margin(%) | 15.99 | 15.77 | 15.25 | 10.01 |
Pre Tax Margin(%) | 13.84 | 14.01 | 14.19 | 9.04 |
PAT Margin (%) | 11.32 | 10.71 | 10.56 | 6.71 |
Cash Profit Margin (%) | 13.27 | 12.37 | 11.67 | 7.97 |
ROA(%) | 15.86 | 17.8 | 23.31 | 13.05 |
ROE(%) | 30.52 | 30.08 | 33.88 | 17.7 |
ROCE(%) | 25.34 | 29.86 | 37.75 | 21.49 |
Receivable days | 45.11 | 38.95 | 30.92 | 35.15 |
Inventory Days | 41.97 | 37.06 | 32.72 | 42.24 |
Payable days | 11.78 | 12.2 | 8.14 | 7.53 |
PER(x) | 0 | 22.94 | 28.85 | 27.36 |
Price/Book(x) | 0 | 5.78 | 8.44 | 4.59 |
Dividend Yield(%) | 0 | 0.47 | 0.86 | 0.82 |
EV/Net Sales(x) | 0 | 2.6 | 3.14 | 1.91 |
EV/Core EBITDA(x) | 0 | 14.92 | 19.21 | 16.99 |
Net Sales Growth(%) | 0 | 29.39 | 62.19 | 0.76 |
EBIT Growth(%) | 0 | 27.64 | 56.86 | -33.89 |
PAT Growth(%) | 0 | 22.42 | 59.84 | -35.94 |
EPS Growth(%) | 0 | 0 | 59.84 | -35.94 |
Debt/Equity(x) | 0.59 | 0.34 | 0.27 | 0.19 |
Current Ratio(x) | 1.19 | 1.93 | 2.04 | 2.22 |
Quick Ratio(x) | 0.63 | 1.03 | 1 | 1.03 |
Interest Cover(x) | 7.45 | 8.96 | 14.31 | 10.36 |
Total Debt/Mcap(x) | 0 | 0.06 | 0.03 | 0.04 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 58.89 | 58.88 | 58.88 | 58.86 | 58.88 | 58.88 | 58.88 | 58.88 | 58.88 | 58.88 |
FII | 6.22 | 6.34 | 6.15 | 6.22 | 6.24 | 6.23 | 6.24 | 6.19 | 6.22 | 6.29 |
DII | 5.32 | 5.38 | 5.46 | 5.48 | 5.4 | 5.19 | 5.23 | 5.34 | 5.28 | 5.26 |
Public | 29.56 | 29.39 | 29.5 | 29.45 | 29.48 | 29.69 | 29.66 | 29.59 | 29.62 | 29.56 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Public | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 | 0.38 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About